USA Rare Earth Appoints Former GlobalFoundries CEO Thomas Caulfield to Board of Directors
USAR has more than doubled off its 52-week low of $5.56.
Summary
USA Rare Earth, Inc. announced the appointment of Dr. Thomas Caulfield, former CEO of GlobalFoundries, to its Board of Directors, bringing significant executive and operational experience to support the company's strategic growth initiatives.
Key Events · Executive and Board Changes · USAR
-
New Director Appointed
Dr. Thomas Caulfield, former President and CEO of GlobalFoundries, was appointed to the Board of Directors, effective March 9, 2026. He will also serve on the Compensation Committee and the Nominating and Corporate Governance Committee.
-
Director Resignation
Tready Smith resigned from the Board of Directors on March 9, 2026. Her resignation was not due to any disagreement with the company.
-
Board Composition Maintained
Following the changes, the Board of Directors continues to have a total of eight members.
-
Annual Meeting Date Set
The Board determined that the 2026 Annual Meeting of Shareholders will be held on June 3, 2026. This will be the company's first annual meeting.
Analysis · USAR · Energy & Transportation
USA Rare Earth, Inc. has appointed Dr. Thomas Caulfield, former President and CEO of GlobalFoundries, to its Board of Directors. This is a significant addition, as Dr. Caulfield brings extensive experience in scaling complex industrial platforms and leading a company through a successful IPO, which is highly relevant given USA Rare Earth's strategic initiatives, including a recent major acquisition and potential government funding for its mine-to-magnet platform. His expertise strengthens the board's capacity for operational execution and strategic oversight during a pivotal growth phase for the company. The resignation of Tready Smith is noted as not being due to any disagreement, maintaining a neutral impact.
At the time of this filing, USAR was trading at $20.79 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $5.56 to $43.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.